Investor Presentation March 2023

Long Term Targets High-Single Digit to Low- double Digits Mid- to High- Single Digits Low- to Mid- Double Digits Combined Organic Revenue Growth Research Models Revenue Growth Preclinical Revenue Growth 18% -22% 2x-3x EBITDA Margin Long Term Net Leverage Multiple 24

View entire presentation